Company intelligence / Profile preview

MDimune Inc.

Seoul, Seoul, South Koreamdimune.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

MDimune has demonstrated preclinical efficacy of its MSC-CDV therapeutics in multiple disease models including cancer and inflammatory conditions. The company has developed a GMP-compliant manufacturing process for CDVs with high yield and functional similarity to natural EVs. Clinical trials are anticipated soon but no human data yet published as of early 2024

Therapeutic areas
GastroenterologyCardiovascularOphthalmologyImmunologyOncologyNeurology
Modalities
cell-derived vesicles (CDVs)extracellular vesicles (EVs)mRNAmiRNAmesenchymal stem cell therapybiological products
Industry
Biotech
02

Drug pipeline

12 assets

BDR-662

Preclinical

11 more assets in the full pipeline.

Request access →
03

Partnerships

Johnson & Johnson Innovation – JLABS @ Shanghai residencycollaborations with Hanyang Universityseeking global pharma/biotech partnerships for technology application and commercialization

Beyond the preview

Go deeper on MDimune Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDimune Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call